Breast cancer can be classified into four molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2- (HER2-) enriched, and triple negative) that present with distinctly different prognoses and treatment responses [1, 2]. Here, ERBB2 is linked to breast cancer.